ERBB2 and glioblastoma: For example, intracranial or intraventricular delivery strategies have been used in clinical studies targeting IL-13 receptor alpha 2 (IL-13Rα2) and HER2 in GBM patients, which has led to increased CAR T cell accumulation at the tumor site and, in certain cases, tumor regression 62.